Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

SHE/300347 stock hub

SHE/300347 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300347is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

41.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300347

In the news

Latest news · SHE/300347

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E39.3

P25 17.1P50 24.2P75 37.8

Trailing P/E55.9

P25 23.5P50 41.3P75 83.2

ROE4.2

P25 -0.9P50 4.1P75 8.8

ROIC2.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300347 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

CNY

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	11,130
Employees Change	945%
Employees Change Percent	9.28
Enterprise value	CNY 44.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	CNE100001KV8
Last refreshed	2026-05-10
Market cap	CNY 41.5B
Price	CNY 51.16
Price currency	CNY
Rev Per Employee	635,231.89x
Sector	Healthcare
Sic	8731
Symbol	she/300347
Website	https://www.tigermedgrp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.86%
EV Earnings	57.95x
EV/EBIT	73.21x
EV/EBITDA	47.61x
EV/FCF	43.78x
EV/Sales	6.32x
FCF yield	2.46%
Forward P/E	39.32x
P/B ratio	1.69x
P/E ratio	55.87x
P/S ratio	5.87x
PE Ratio10 Y	61.81x
PE Ratio3 Y	62.56x
PE Ratio5 Y	55.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.64%
EBITDA Margin	11.66%
FCF margin	14.44%
Gross margin	26.64%
Gross Profit	CNY 1.9B
Gross Profit Growth	-9.71%
Gross Profit Growth Q	2.16%
Gross Profit Growth3 Y	-12.57%
Gross Profit Growth5 Y	2.85%
Net Income	CNY 771.5M
Net Income Growth	129.92%
Net Income Growth Q	-70.36%
Net Income Growth Years	1%
Net Income Growth3 Y	-27.88%
Net Income Growth5 Y	-16.93%
Pretax Margin	17.9%
Profit Margin	10.91%
Profit Per Employee	CNY 69,314
Profitable Years	17
ROA	1.33
Roa5y	3.08
ROCE	2.36
ROE	4.23
Roe5y	8.49
ROIC	2.05
Roic5y	6.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.28%
Cagr1y	12%
Cagr3y	-15.8%
Cagr5y	-18.3%
Div CAGR10	16.23%
Div CAGR3	-18.29%
Div CAGR5	0%
EPS Growth	135.5
EPS Growth Q	-68.42
EPS Growth Years	1
EPS Growth3 Y	-27.27
EPS Growth5 Y	-17.17
FCF Growth	19.07%
FCF Growth Q	78.37%
FCF Growth3 Y	18.53%
FCF Growth5 Y	2.66%
OCF Growth	7.57%
OCF Growth Q	60.51%
OCF Growth10 Y	24.78%
OCF Growth3 Y	4.56%
OCF Growth5 Y	1.52%
Revenue Growth	8.65x
Revenue Growth Q	15.17x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.01x
Revenue Growth5 Y	15.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.25
Assets	CNY 28.8B
Cash	CNY 2.2B
Current Assets	CNY 6.6B
Current Liabilities	CNY 2.9B
Debt	CNY 1.7B
Debt EBITDA	CNY 1.83
Debt Equity	CNY 0.07
Debt FCF	CNY 1.69
Equity	CNY 24.6B
Interest Coverage	7.54
Liabilities	CNY 4.2B
Long Term Assets	CNY 22.2B
Long Term Liabilities	CNY 1.4B
Net Cash	CNY 479.6M
Net Cash By Market Cap	CNY 1.15
Net Debt EBITDA	CNY -0.58
Net Debt Equity	CNY -0.02
Net Debt FCF	CNY -0.47
Tangible Book Value	CNY 17.2B
Tangible Book Value Per Share	CNY 20.09
WACC	7.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.3
Inventory Turnover	112.3
Net Working Capital	CNY 2.1B
Quick ratio	2.22
Working Capital	CNY 3.7B
Working Capital Turnover	CNY 2.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.39%
Dividend Growth	-47.18%
Dividend Growth Years	0%
Dividend per share	CNY 0.13
Dividend Years	13
Dividend Yield	0.25%
Ex Div Date	2025-06-17
Last Dividend	CNY 0.3
Payout Frequency	Annual
Payout Ratio	42.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	166.03%
1Y total return	11.99%
200-day SMA	58.18
3Y total return	-40.32%
50-day SMA	55.67
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.58%
All Time High	209.4
All Time High Change	-75.57%
All Time High Date	2021-07-01
All Time Low	3.92
All Time Low Change	1,206.1%
All Time Low Date	2012-08-17
ATR	2.29
Beta	0.62
Beta1y	0.09
Beta2y	0.6
Ch YTD	-9.77
High	53.65
High52	71.9
High52 Date	2025-07-30
High52ch	-28.85%
Low	51.15
Low52	41.61
Low52 Date	2025-05-16
Low52ch	22.95%
Ma50ch	-8.11%
Price vs 200-day SMA	-12.07%
RSI	35.52
RSI Monthly	44.58
RSI Weekly	42.34
Sharpe ratio	0.47x
Sortino ratio	0.96
Total Return	2.63%
Tr YTD	-9.77
Tr1m	-7.7%
Tr1w	-5.22%
Tr3m	-22.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 610.6M
Operating Income Growth	-28
Operating Income Growth Q	1.22
Operating Income Growth3 Y	-29.34
Operating Income Growth5 Y	-8.52
Operating margin	8.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	616,872,831%
Net Borrowing	-1,532,674,134
Shares Insiders	27.86%
Shares Institutions	33.67%
Shares Out	855,142,270
Shares Qo Q	-3.95%
Shares Yo Y	-2.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1B
Average Volume	13,129,714.1x
Bv Per Share	24.46
CAPEX	CNY -216.7M
Ch10y	152.4
Ch1m	-7.7
Ch1w	-5.22
Ch1y	11.34
Ch3m	-22.07
Ch3y	-41.86
Ch5y	-64.8
Ch6m	-12.28
Change	-3.71%
Change From Open	-3.47
Close	53.13
Days Gap	-0.24
Depreciation Amortization	213,489,020
Dollar Volume	743,709,134.2
Earnings Date	2026-04-29
EBIT	CNY 610.6M
EBITDA	CNY 824.1M
EPS	CNY 0.92
F Score	6
FCF	CNY 1B
FCF EV Yield	2.28x
FCF Per Share	CNY 1.19
Financing CF	-1,815,244,233
Fiscal Year End	December
Founded	2,004
Goodwill	3,484,849,857
Graham Number	25.43537
Graham Upside	-50.28
Income Tax	CNY 240.4M
Investing CF	1,203,662,046
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2019-07-01
Last Split Type	Forward
Lynch Fair Value	CNY 4.75
Lynch Upside	-90.71
Ma150	56.29
Ma150ch	-9.12%
Ma20	56.55
Ma20ch	-9.53%
Net CF	598,015,845
Next Earnings Date	2026-08-25
Open	53
P FCF Ratio	40.67
P OCF Ratio	33.55
Payment Date	2025-06-17
Position In Range	0.4
Ppne	1,680,713,346
Price Date	2026-05-08
Price EBITDA	CNY 50.4
Ptbv Ratio	2.42
Relative Volume	1.16x
Revenue	7,070,130,935x
Tax By Revenue	3.4x
Tax Rate	18.99%
Tr6m	-12.28%
Volume	14,536,926
Z Score	7.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300347 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.13 annual per share

Payout ratio

+43.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+2.6%

Next ex-dividend date: 2025-06-17

Performance

SHE/300347 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300347?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.7%

Share of float held by funds and institutions

Insider ownership

+27.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.4%

Negative means the company is buying back shares.

Technical

SHE/300347 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.5

Neutral momentum band

Price vs 200-day MA

-12.1%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300347

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300347 stock rating?

she/300347 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300347 analysis?

The full report lives at /stocks/she/300347/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300347?

The latest report frames she/300347 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300347 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.